GeoVax Labs Inc.

Last updated September 27, 2026

Organization details

Legal name
GeoVax Labs Inc.
Former names
Dauphin Technology Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Smyrna
Headquarters state / province
Georgia
Headquarters country
United States
Fiscal year end
December
Ticker symbol
GOVX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000832489
EIN
87-0455038

Board of directors

Chief executives

David A. Dodd · President, CEO
Dates unknown

Director election results

Annual meeting of June 5, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 4 other boards. 3 are in the same sector.

Network of GeoVax Labs Inc.'s board connections BioRestorative Therapies Inc. BioRestorative Therapi... GridAI Technologies Corp. GridAI Technologies Co... InMed Pharmaceuticals Inc. InMed Pharmaceuticals... Medicinova Inc Medicinova Inc Manpreet Uppal Manpreet Uppal Nicole Lemerond Nicole Lemerond Steven Collier Brown Steven Collier Brown GeoVax Labs Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 17, 2025 John N. Spencer Jr. Director Open-market purchase +10,000 $0.55 $5,500
Aug 7, 2025 McKee Kelly T. Jr. Officer (Chief Medical Officer) Open-market purchase +1,107 $0.67 $742
Apr 10, 2025 John N. Spencer Jr. Director Open-market purchase +10,000 $0.98 $9,800
Apr 10, 2025 Sharkey John W. Officer (VP, Business Development) Open-market purchase +6,000 $0.99 $5,940
Apr 1, 2025 David A. Dodd Director, Officer (President, CEO) Open-market purchase +10,000 $1.08 $10,800
Mar 31, 2025 Reynolds Mark Officer (CFO) Open-market purchase +6,800 $1.08 $7,344
Aug 9, 2024 David A. Dodd Director, Officer (President, CEO) Open-market purchase +8,000 $1.95 $15,600
Feb 22, 2024 David A. Dodd Director, Officer (President, CEO) Open-market purchase +8,209 $2.27 $18,634
Feb 21, 2024 David A. Dodd Director, Officer (President, CEO) Open-market purchase +520 $2.15 $1,118
Feb 7, 2024 Reynolds Mark Officer (CFO) Open-market purchase +2,000 $2.77 $5,540
Dec 22, 2023 McKee Kelly T. Jr. Officer (Chief Medical Officer) Open-market purchase +6,944 $0.36 $2,500
Sep 25, 2023 McKee Kelly T. Jr. Officer (Chief Medical Officer) Open-market purchase +9,653 $0.52 $5,020
Aug 25, 2023 David A. Dodd Director, Officer (President, CEO) Open-market purchase +35,087 $0.57 $20,000
Aug 18, 2023 Reynolds Mark Officer (CFO) Open-market purchase +10,000 $0.52 $5,200
Apr 24, 2023 David A. Dodd Director, Officer (President, CEO) Open-market purchase +32,000 $0.64 $20,480

Organizations in the same sector, closest in location and size first.

Questions about GeoVax Labs Inc.

Who is the CEO of GeoVax Labs Inc.?

David A. Dodd is GeoVax Labs Inc.'s President, CEO.

How many directors are on GeoVax Labs Inc.'s board?

GeoVax Labs Inc.'s board has 9 directors: David A. Dodd, Dean G. Kollintzas, Jayne Morgan, John N. Spencer Jr., Manpreet Uppal, Nicole Lemerond, Randal D. Chase, Robert T. Mcnally and Steven Collier Brown.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="geovax-labs-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.